Brokerages Set Agilon Health, Inc. (NYSE:AGL) PT at $2.73

Agilon Health, Inc. (NYSE:AGL) has received an average rating of “Hold” from the eighteen brokerages that are covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, twelve have assigned a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $2.7308.

Several brokerages have recently weighed in on AGL. Benchmark lowered their price objective on shares of Agilon Health from $4.00 to $1.50 and set a “buy” rating on the stock in a research note on Wednesday, August 6th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Agilon Health in a research report on Wednesday, October 8th. Barclays dropped their price target on shares of Agilon Health from $1.50 to $1.00 and set an “underweight” rating on the stock in a research note on Thursday, November 6th. Wells Fargo & Company reduced their price objective on Agilon Health from $1.50 to $1.00 and set an “overweight” rating for the company in a research note on Wednesday, November 5th. Finally, Zacks Research upgraded Agilon Health from a “strong sell” rating to a “hold” rating in a research report on Tuesday, October 21st.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in AGL. Nisa Investment Advisors LLC lifted its holdings in Agilon Health by 244.9% during the first quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company’s stock valued at $41,000 after purchasing an additional 6,783 shares in the last quarter. Gabelli Funds LLC bought a new stake in shares of Agilon Health during the 1st quarter valued at $48,000. Arrowpoint Investment Partners Singapore Pte. Ltd. purchased a new position in shares of Agilon Health during the 2nd quarter valued at $31,000. 111 Capital bought a new position in Agilon Health in the 2nd quarter worth $36,000. Finally, Signaturefd LLC boosted its holdings in Agilon Health by 28.3% in the 1st quarter. Signaturefd LLC now owns 18,461 shares of the company’s stock worth $80,000 after buying an additional 4,073 shares during the period.

Agilon Health Price Performance

AGL stock opened at $0.51 on Friday. Agilon Health has a 1 year low of $0.51 and a 1 year high of $6.08. The company has a market cap of $213.09 million, a P/E ratio of -0.69 and a beta of 0.05. The stock’s fifty day moving average price is $0.92 and its 200-day moving average price is $1.62.

Agilon Health (NYSE:AGL) last posted its earnings results on Tuesday, November 4th. The company reported ($0.27) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.09). The firm had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.43 billion. Agilon Health had a negative net margin of 5.24% and a negative return on equity of 75.92%. Agilon Health has set its FY 2025 guidance at EPS. As a group, analysts expect that Agilon Health will post -0.59 earnings per share for the current year.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.